Apicoplast fatty acid biosynthesis as a target for medical intervention in apicomplexan parasites

International Journal for Parasitology

Volumn 33, Issue 9, 2003, Pages 885-896

  Gornicki, Piotr ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apicomplexa; Apicoplast; Biosynthesis; Fatty acid; Inhibitor; Parasite

Indexed keywords

3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE; ACETYL COENZYME A CARBOXYLASE; CERULENIN; ENZYME INHIBITOR; FATTY ACID; THIOLACTOMYCIN; TRICLOSAN;

PARASITE;

APICOMPLEXA; APICOPLAST; CHEMICAL STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID SYNTHESIS; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; MICROBIAL METABOLISM; NONHUMAN; PLASMODIUM FALCIPARUM; PROTOZOAL GENETICS; REVIEW;

ANIMALIA; APICOMPLEXA; PLASMODIUM FALCIPARUM;

EID: 0142061141     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(03)00133-4     Document Type: Review

References (78)

1. Azzouz N., Rauscher B., Gerold P., Cesbron-Delauw M.F., Dubremetz J.F., Schwarz R.T. Evidence for de novo sphingolipid biosynthesis in Toxoplasma gondii. Int. J. Parasitol. 32:2002;677-684.
2. Bahl A., Brunk B., Coppel R.L., Crabtree J., Diskin S.J., Fraunholz M.J., Grant G.R., Gupta D., Huestis R.L., Kissinger J.C., Labo P., Li L., McWeeney S.K., Milgram A.J., Roos D.S., Schug J., Stoeckert C.J. Jr. PlasmoDB: the Plasmodium genome resource. An integrated database providing tools for accessing, analyzing and mapping expression and sequence data (both finished and unfinished). Nucleic Acids Res. 30:2002;87-90.
3. Baldauf S.L., Roger A.J., Wenk-Siefert I., Doolittle W.F. A kingdom-level phylogeny of eukaryotes based on combined protein data. Science. 290:2000;972-977.
4. Campbell J.W., Cronan J.E. Jr. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu. Rev. Microbiol. 55:2001;305-332.
5. Camps M., Arrizabalaga G., Boothroyd J. An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii. Mol. Microbiol. 43:2002;1309-1318.
6. Carlton J.M., Angiuoli S.V., Suh B.B., Kooij T.W., Pertea M., Silva J.C., Ermolaeva M.D., Allen J.E., Selengut J.D., Koo H.L., Peterson J.D., Pop M., Kosack D.S., Shumway M.F., Bidwell S.L., Shallom S.J., van Aken S.E., Riedmuller S.B., Feldblyum T.V., Cho J.K., Quackenbush J., Sedegah M., Shoaibi A., Cummings L.M., Florens L., Yates J.R., Raine J.D., Sinden R.E., Harris M.A., Cunningham D.A., Preiser P.R., Bergman L.W., Vaidya A.B., van Lin L.H., Janse C.J., Waters A.P., Smith H.O., White O.R., Salzberg S.L., Venter J.C., Fraser C.M., Hoffman S.L., Gardner M.J., Carucci D.J. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii. Nature. 419:2002;512-519.
7. Carlton J.M., Carucci D.J. Rodent models of malaria in the genomics era. Trends Parasitol. 18:2002;100-102.
8. Carucci D.J. Functional genomic technologies applied to the control of the human malaria parasite, Plasmodium falciparum. Pharmacogenomics. 2:2001;137-142.
9. Cascante M., Boros L.G., Comin-Anduix B., de Atauri P., Centelles J.J., Lee P.W.N. Metabolic control analysis in drug discovery and disease. Nat. Biotechnol. 20:2002;243-249.
10. Charron A.J., Sibley L.D. Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. J. Cell Sci. 115:2002;3049-3059.
11. Chirala S.S., Jayakumar A., Gu Z.W., Wakil S.J. Human fatty acid synthase: role of interdomain in the formation of catalytically active synthase dimer. Proc. Natl Acad. Sci. USA. 98:2001;3104-3108.
12. Coombs G.H., Muller S. Recent advances in the search for new anti-coccidial drugs. Int. J. Parasitol. 32:2002;497-508.
13. Cronan J.E. Jr., Waldrop G.L. Multi-subunit acetyl-CoA carboxylases. Prog. Lipid Res. 41:2002;407-435.
14. DeRocher A., Hagen C.B., Froehlich J.E., Feagin J.E., Parsons M. Analysis of targeting sequences demonstrates that trafficking to the Toxoplasma gondii plastid branches off the secretory system. J. Cell Sci. 113:2000;3969-3977.
15. Derouin F. Anti-toxoplasmosis drugs. Curr. Opin. Investig. Drugs. 2:2001;1368-1374.
16. Devine M.D. Mechanism of resistance to acetyl-coenzyme A carboxylase inhibitors: a review. Pestic. Sci. 51:1997;259-264.
17. Devine M.D., Shukla A. Altered target sites as mechanism of herbicide resistance. Crop Prot. 19:2000;881-889.
18. Fichera M.E., Roos D.S. A plastid organelle as a drug target in apicomplexan parasites. Nature. 390:1997;407-409.
19. Foth B.J., Ralph S.A., Tonkin C.J., Struck N.S., Fraunholz M., Roos D.S., Cowman A.F., McFadden G.I. Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. Science. 299:2003;705-708.
20. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K., Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S., Chan M.S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M.A., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I., Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J., Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 419:2002;498-511.
21. Gerold P., Schwarz R.T. Biosynthesis of glycosphingolipids de-novo by the human malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 112:2001;29-37.
22. Gleeson M.T. The plastid in Apicomplexa: what use is it? Int. J. Parasitol. 30:2000;1053-1070.
23. Greenwood B., Mutabingwa T. Malaria in 2002. Nature. 415:2002;670-672.
24. Gueguen V., Macherel D., Jaquinod M., Douce R., Bourguignon J. Fatty acid and lipoic acid biosynthesis in higher plant mitochondria. J. Biol. Chem. 275:2000;5016-5025.
25. Harwood J.L. Recent advances in the biosynthesis of plant fatty acids. Biochim. Biophys. Acta. 1301:1996;7-56.
26. He C.Y., Shaw M.K., Pletcher C.H., Striepen B., Tilney L.G., Roos D.S. A plastid segregation defect in the protozoan parasite Toxoplasma gondii. EMBO J. 20:2001;330-339.
27. Heath R.J., White S.W., Rock C.O. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40:2001;467-497.
28. Heath R.J., White S.W., Rock C.O. Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics. Appl. Microbiol. Biotechnol. 58:2002;695-703.
29. Herbert D., Walker K.A., Price L.J., Cole D.J., Pallett K.E., Ridley S.M., Harwood J.L. Acetyl-CoA carbnoxylase - a graminicide target site. Pestic. Sci. 50:1997;67-71.
30. Hill D., Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin. Microbiol. Infect. 8:2002;634-640.
31. Huang S.X., Sirikhachornkit A., Faris J.D., Su X.J., Gill B.S., Haselkorn R., Gornicki P. Phylogenetic analysis of the acetyl-CoA carboxylase and 3-phosphoglycerate kinase loci in wheat and other grasses. Plant Mol. Biol. 48:2002;805-820.
32. Incledon B.J., Hall J.C. Acetyl-coenzyme A carboxylase: quaternary structure and inhibition by graminicidal herbicides. Pestic. Biochem. Physiol. 57:1997;255-271.
33. Jelenska J., Crawford M.J., Harb O.S., Zuther E., Haselkorn R., Roos D.S., Gornicki P. Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii. Proc. Natl Acad. Sci. USA. 98:2001;2723-2728.
34. Jelenska J., Sirikhachornkit A., Haselkorn R., Gornicki P. The carboxyltransferase activity of the apicoplast acetyl-CoA carboxylase of Toxoplasma gondii is the target of aryloxyphenoxypropionate inhibitors. J. Biol. Chem. 277:2002;23208-23215.
35. Joachimiak M., Tevzadze G., Podkowinski J., Haselkorn R., Gornicki P. Wheat cytosolic acetyl-CoA carboxylase complements an ACC1 null mutation in yeast. Proc. Natl Acad. Sci. USA. 94:1997;9990-9995.
36. Jomaa H., Wiesner J., Sanderbrand S., Altincicek B., Weidemeyer C., Hintz M., Turbachova I., Eberl M., Zeidler J., Lichtenthaler H.K., Soldati D., Beck E. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science. 285:1999;1573-1576.
37. Joshi A.K., Rangan V.S., Witkowski A., Smith S. Engineering of an active animal fatty acid synthase dimer with only one competent subunit. Chem. Biol. 10:2003;169-173.
38. Kaasch A.J., Joiner K.A. Targeting and subcellular localization of Toxoplasma gondii catalase. Identification of peroxisomes in an apicomplexan parasite. J. Biol. Chem. 275:2000;1112-1118.
39. Kapoor M., Dar M.J., Surolia A., Surolia N. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. Biochem. Biophys. Res. Commun. 289:2001;832-837.
40. Kissinger J.C., Brunk B.P., Crabtree J., Fraunholz M.J., Gajria B., Milgram A.J., Pearson D.S., Schug J., Bahl A., Diskin S.J., Ginsburg H., Grant G.R., Gupta D., Labo P., Li L., Mailman M.D., McWeeney S.K., Whetzel P., Stoeckert C.J., Roos D.S. The Plasmodium genome database - designing and mining a eukaryotic genomics resource. Nature. 419:2002;490-492.
41. Kissinger J.C., Gajria B., Li L., Paulsen I.T., Roos D.S. ToxoDB: accessing the Toxoplasma gondii genome. Nucleic Acids Res. 31:2003;234-236.
42. Kuhajda F.P. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 16:2000;202-208.
43. Kuo M.R., Morbidoni H.R., Alland D., Sneddon S.F., Gourlie B.B., Staveski M.M., Leonard M., Gregory J.S., Janjigian A.D., Yee C., Kreiswirth B., Iwamoto H., Perozzo R., Jacobs W.R. Jr., Sacchettini J.C., Fidock D.A. Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural data. J. Biol. Chem. 26:2003;26.
44. Li L., Brunk B.P., Kissinger J.C., Pape D., Tang K., Cole R.H., Martin J., Wylie T., Dante M., Fogarty S.J., Howe D.K., Liberator P., Diaz C., Anderson J., White M., Jerome M.E., Johnson E.A., Radke J.A., Stoeckert C.J. Jr, Waterston R.H., Clifton S.W., Roos D.S., Sibley L.D. Gene discovery in the Apicomplexa as revealed by EST sequencing and assembly of a comparative gene database. Genome Res. 13:2003;443-454.
45. Macreadie I., Ginsburg H., Sirawaraporn W., Tilley L. Antimalarial drug development and new targets. Parasitol. Today. 16:2000;438-444.
46. Marechal E., Azzouz N., de Macedo C.S., Block M.A., Feagin J.E., Schwarz R.T., Joyard J. Synthesis of chloroplast galactolipids in apicomplexan parasites. Eukaryot. Cell. 1:2002;653-656.
47. Martin W., Stoebe B., Goremykin V., Hansmann S., Hasegava M., Kowallik K.V. Gene transfer to the nucleus and the evolution of chloroplasts. Nature. 393:1998;162-165.
48. McFadden D.C., Camps M., Boothroyd J.C. Resistance as a tool in the study of old and new drug targets in Toxoplasma. Drug Resist. Update. 4:2001;79-84.
49. McFadden G.I., Roos D.S. Apicomplexan plastids as drug targets. Trends Microbiol. 7:1999;328-333.
50. McLeod R., Muench S.P., Rafferty J.B., Kyle D.E., Mui E.J., Kirisits M.J., Mack D.G., Roberts C.W., Samuel B.U., Lyons R.E., Dorris M., Milhous W.K., Rice D.W. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. Int. J. Parasitol. 31:2001;109-113.
51. Munday M.R., Hemingway C.J. The regulation of acetyl-CoA carboxylase - a potential target for the action of hypolipidemic agents. Adv. Enzyme Regul. 39:1999;205-234.
52. Neuhaus H.E., Emes M.J. Nonphotosynthetic metabolism in plastids. Annu. Rev. Plant Physiol. Mol. Biol. 51:2000;111-140.
53. Nikolskaya T., Zagnitko O., Tevzadze G., Haselkorn R., Gornicki P. Herbicide sensitivity determinant of wheat plastid acetyl-CoA carboxylase is located in a 400-amino acid fragment of the carboxyltransferase domain. Proc. Natl Acad. Sci. USA. 96:1999;14647-14651.
54. Perozzo R., Kuo M., Sidhu A.S., Valiyaveettil J.T., Bittman R., Jacobs W.R. Jr, Fidock D.A., Sacchettini J.C. Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. J. Biol. Chem. 277:2002;13106-13114.
55. Prigge S.T., He X., Gerena L., Waters N.C., Reynolds K.A. The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII. Biochemistry. 42:2003;1160-1169.
56. Ralph S.A., D'Ombrain M.C., McFadden G.I. The apicoplast as an antimalarial drug target. Drug Resist. Update. 4:2001;145-151.
57. Ridley R.G. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature. 415:2002;686-693.
58. Roberts C.W., McLeod R., Rice D.W., Ginger M., Chance M.L., Goad L.J. Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Mol. Biochem. Parasitol. 126:2003;129-142.
59. Rock C.O., Jackowski S. Forty years of bacterial fatty acid synthesis. Biochem. Biophys. Res. Commun. 292:2002;1155-1166.
60. Roos D.S., Crawford M.J., Donald R.G., Fraunholz M., Harb O.S., He C.Y., Kissinger J.C., Shaw M.K., Striepen B. Mining the Plasmodium genome database to define organellar function: what does the apicoplast do? Philos. Trans. R. Soc. Lond. B Biol. Sci. 357:2002;35-46.
61. Shaw M.K. Cell invasion by Theileria sporozoites. Trends Parasitol. 19:2003;2-6.
62. Sibley C.H., Brophy V.H., Cheesman S., Hamilton K.L., Hankins E.G., Wooden J.M., Kilbey B. Yeast as a model system to study drugs effective against apicomplexan proteins. Methods. 13:1997;190-207.
63. Surolia N., Surolia A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat. Med. 7:2001;167-173.
64. Tenter A.M., Barta J.R., Beveridge I., Duszynski D.W., Mehlhorn H., Morrison D.A., Thompson R.C.A., Conrad P.A. The conceptual basis for a new classification of the coccidia. Int. J. Parasitol. 32:2002;595-616.
65. van Dooren G.G., Su V., D'Ombrain M.C., McFadden G.I. Processing of an apicoplast leader sequence in Plasmodium falciparum and the identification of a putative leader cleavage enzyme. J. Biol. Chem. 277:2002;23612-23619.
66. Vial H.J., Eldin P., Tielens A.G., van Hellemond J.J. Phospholipids in parasitic protozoa. Mol. Biochem. Parasitol. 126:2003;143-154.
67. Waller R.F., Keeling P.J., Donald R.G., Striepen B., Handman E., Lang-Unnasch N., Cowman A.F., Besra G.S., Roos D.S., McFadden G.I. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc. Natl Acad. Sci. USA. 95:1998;12352-12357.
68. Waller R.F., Ralph S.A., Reed M.B., Su V., Douglas J.D., Minnikin D.E., Cowman A.F., Besra G.S., McFadden G.I. A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum. Antimicrob. Agents Chemother. 47:2003;297-301.
69. Waller R.F., Reed M.B., Cowman A.F., McFadden G.I. Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway. EMBO J. 19:2000;1794-1802.
70. Ward G.E., Carey K.L., Westwood N.J. Using small molecules to study big questions in cellular microbiology. Cell Microbiol. 4:2002;471-482.
71. Waters N.C., Kopydlowski K.M., Guszczynski T., Wei L., Sellers P., Ferlan J.T., Lee P.J., Li Z., Woodard C.L., Shallom S., Gardner M.J., Prigge S.T. Functional characterization of the acyl carrier protein (PfACP) and beta-ketoacyl ACP synthase III (PfKASIII) from Plasmodium falciparum. Mol. Biochem. Parasitol. 123:2002;85-94.
72. Wilson R.J.M. Progress with parasite plastids. J. Mol. Biol. 319:2002;257-274.
73. Zagnitko O., Jelenska J., Tevzadze G., Haselkorn R., Gornicki P. An isoleucine/leucine residue in the carboxyltransferase domain of acetyl-CoA carboxylase is critical for interaction with aryloxyphenoxypropionate and cyclohexanedione inhibitors. Proc. Natl Acad. Sci. USA. 98:2001;6617-6622.
74. Zhang H., Yang Z., Shen Y., Tong L. Crystal structure of the carboxyltransferase domain of acetyl-coenzyme A carboxylase. Science. 299:2003;2064-2067.
75. Zhu G., Keithly J.S., Philippe H. What is the phylogenetic position of Cryptosporidium? Int. J. Syst. Evol. Microbiol. 50:2000;1673-1681.
76. Zhu G., Marchewka M.J., Keithly J.S. Cryptosporidium parvum appears to lack a plastid genome. Microbiology-UK. 146:2000;315-321.
77. Zuegge J., Ralph S., Schmuker M., McFadden G.I., Schneider G. Deciphering apicoplast targeting signals - feature extraction from nuclear-encoded precursors of Plasmodium falciparum apicoplast proteins. Gene. 280:2001;19-26.
78. Zuther E., Johnson J.J., Haselkorn R., McLeod R., Gornicki P. Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase. Proc. Natl Acad. Sci. USA. 96:1999;13387-13392.